Published in Cochrane Database Syst Rev on April 16, 2008
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst (2009) 2.55
Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer (2010) 2.25
Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation (2009) 1.62
Drug-induced oxidative stress and toxicity. J Toxicol (2012) 1.55
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol (2010) 1.52
Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27. PLoS One (2011) 1.05
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol (2015) 0.99
Strategies to prevent anthracycline-related congestive heart failure in survivors of childhood cancer. Cardiol Res Pract (2012) 0.87
Cardiovascular complications of breast cancer therapy in older adults. Oncologist (2011) 0.85
Dexrazoxane for preventing anthracycline cardiotoxicity in children with solid tumors. J Korean Med Sci (2010) 0.81
Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs. Biomed Res Int (2015) 0.81
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection. Heart Fail Rev (2015) 0.79
Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphoma. Hematol Rep (2011) 0.79
Effects of MnDPDP and ICRF-187 on Doxorubicin-Induced Cardiotoxicity and Anticancer Activity. Transl Oncol (2012) 0.78
Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms. BMC Cancer (2014) 0.78
An update on cardio-oncology. Trends Cardiovasc Med (2014) 0.78
Dexrazoxane as a cardioprotectant in children receiving anthracyclines. Oncologist (2010) 0.77
Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients. Br J Clin Pharmacol (2014) 0.77
Cardiovascular effects of noncardiovascular drugs. Circulation (2009) 0.76
Moving forward with new data and approaches: a fresh look at anthracyclines in non-Hodgkin's lymphoma. Hematol Rep (2011) 0.76
SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly. Hematol Rep (2011) 0.75
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology. J Cardiovasc Med (Hagerstown) (2016) 0.75
AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011. Breast Care (Basel) (2011) 0.75
Heart failure in chemotherapy-related cardiomyopathy: Can exercise make a difference? BBA Clin (2016) 0.75
Use of pattern recognition analysis to identify underlying relationships of Doxorubicin derivatives optimized for breast cancer treatment. ISRN Oncol (2011) 0.75
New approaches in the management of advanced breast cancer - role of combination treatment with liposomal doxorubicin. Breast Cancer (Dove Med Press) (2009) 0.75
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure. Korean Circ J (2017) 0.75
Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev (2007) 10.34
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J (2001) 4.85
Stillbirths among offspring of male radiation workers at Sellafield nuclear reprocessing plant. Lancet (1999) 4.18
Stillbirth rates around the nuclear installation at Sellafield, North West England: 1950-1989. Int J Epidemiol (1998) 1.72
Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer (2004) 1.68
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr Blood Cancer (2013) 1.65
Adverse pregnancy outcomes around incinerators and crematoriums in Cumbria, north west England, 1956-93. J Epidemiol Community Health (2003) 1.62
Risk of cardiovascular disease measured by carotid intima-media thickness at age 49-51: lifecourse study. BMJ (2000) 1.57
The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. Ann Oncol (2012) 1.54
Cancer trends in England and Wales. Good data and analysis are vital to improving survival. BMJ (2000) 1.49
Accrual in supportive care trials in pediatric oncology, a challenge! Support Care Cancer (2012) 1.46
[Childhood cancers in the Netherlands (1989-1997)]. Ned Tijdschr Geneeskd (2001) 1.41
A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49-51 years. Diabet Med (2003) 1.37
Diagnostic tests in Hirschsprung disease: a systematic review. J Pediatr Gastroenterol Nutr (2006) 1.34
Quality of life and current coping in young adult survivors of childhood cancer: positive expectations about the further course of the disease were correlated with better quality of life. Psychooncology (2006) 1.27
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation. Cochrane Database Syst Rev (2007) 1.20
Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer (2006) 1.14
Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials. Eur J Cancer (2005) 1.12
USAGE: a web-based approach towards the analysis of SAGE data. Serial Analysis of Gene Expression. Bioinformatics (2000) 1.11
Pain in children with cerebral palsy: a cross-sectional multicentre European study. Acta Paediatr (2009) 1.10
Stillbirth risk with social class and deprivation: no evidence for increasing inequality. J Clin Epidemiol (2000) 1.08
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma. Oncogene (2011) 1.08
Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev (2006) 1.07
The volume effect in paediatric oncology: a systematic review. Ann Oncol (2013) 1.04
Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane Database Syst Rev (2005) 1.04
Seasonality of birth for cancer in Northern England, UK. Paediatr Perinat Epidemiol (2001) 1.00
Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target. Leukemia (2012) 1.00
Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells. Oncogene (2010) 0.99
Granulocyte transfusions in neutropaenic children: a systematic review of the literature. Eur J Cancer (2007) 0.97
Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy. Pediatr Blood Cancer (2010) 0.94
The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. Eur J Cancer (2006) 0.94
Additive isotonic regression models in epidemiology. Stat Med (2000) 0.94
The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability. J Cancer Surviv (2013) 0.93
Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev (2006) 0.92
Why is the sex ratio falling in England and Wales? J Epidemiol Community Health (1996) 0.92
Different anthracycline derivates for reducing cardiotoxicity in cancer patients. Cochrane Database Syst Rev (2006) 0.92
The prognostic value of fast molecular response of marrow disease in patients aged over 1 year with stage 4 neuroblastoma. Eur J Cancer (2011) 0.91
Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review. Eur J Cancer (2004) 0.91
Reproductive status in adult male long-term survivors of childhood cancer. Hum Reprod (2011) 0.91
Sibling self-report, parental proxies, and quality of life: the importance of multiple informants for siblings of a critically ill child. Pediatr Hematol Oncol (2005) 0.90
Quality of life and psychological adaptation in siblings of paediatric cancer patients, 2 years after diagnosis. Psychooncology (2004) 0.90
School-aged children after the end of successful treatment of non-central nervous system cancer: longitudinal assessment of health-related quality of life, anxiety and coping. Eur J Cancer Care (Engl) (2009) 0.89
A novel local treatment strategy for advanced stage head and neck rhabdomyosarcomas in children: results of the AMORE protocol. Eur J Cancer (2003) 0.85
Proximity to maternity services and stillbirth risk. Arch Dis Child Fetal Neonatal Ed (2000) 0.84
Lack of interstitial chromosome 1p deletions in clinically-detected neuroblastoma. Eur J Cancer (2002) 0.83
Psychosocial functioning in siblings of paediatric cancer patients one to six months after diagnosis. Eur J Cancer (2003) 0.83
Mannose-binding lectin and infection risk in newborns: a systematic review. Arch Dis Child Fetal Neonatal Ed (2010) 0.83
Hypertension in long-term survivors of childhood cancer: a nested case-control study. Eur J Cancer (2010) 0.82
The use of liposomal anthracycline analogues for childhood malignancies: A systematic review. Eur J Cancer (2011) 0.81
Mannose-binding lectin (MBL) and the risk for febrile neutropenia and infection in pediatric oncology patients with chemotherapy. Pediatr Blood Cancer (2010) 0.80
Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy. Cochrane Database Syst Rev (2006) 0.80
Childhood solid tumours in relation to population mixing around the time of birth. Br J Cancer (2003) 0.80
Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis. Surgeon (2010) 0.80
Effectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: a systematic review. Int J Geriatr Psychiatry (2007) 0.79
Development of clinical practice guidelines for supportive care in childhood cancer--prioritization of topics using a Delphi approach. Support Care Cancer (2014) 0.79
The AMORE protocol as salvage treatment for non-orbital head and neck rhabdomyosarcoma in children. Eur J Surg Oncol (2004) 0.79
Pseudomembranous and neutropenic enterocolitis in pediatric oncology patients. Support Care Cancer (2003) 0.79
Development of a national protocol to screen Dutch cancer survivors on late cancer treatment effects. Int J Med Inform (2006) 0.78
Bacteraemia in a paediatric oncology unit in South Africa. Med Pediatr Oncol (2001) 0.78
Neuroblastoma 4S with an unfavorable biological marker: what to do? Med Pediatr Oncol (1999) 0.78
Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance. Pediatr Blood Cancer (2013) 0.78
Mannose-binding lectin (MBL) as prognostic factor in paediatric oncology patients. Clin Exp Immunol (2011) 0.77
Are survivors of childhood cancer with an unfavourable psychosocial developmental trajectory more likely to apply for disability benefits? Psychooncology (2011) 0.77
Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma. Eur J Nucl Med Mol Imaging (2014) 0.76
Pediatric oncologists and evidence-based medicine: a postal survey in The Netherlands. Pediatr Blood Cancer (2009) 0.76
Treatment for asymptomatic anthracycline-induced cardiac dysfunction in childhood cancer survivors: the need for evidence. J Clin Oncol (2003) 0.75
Severity of enterocolitis is predicted by IL-8 in paediatric oncology patients. Eur J Cancer (2004) 0.75
Decline in sex ratios at birth, England and Wales, 1973-90. J Epidemiol Community Health (1997) 0.75
Final height in survivors of childhood cancer compared with Height Standard Deviation Scores at diagnosis. Ann Oncol (2012) 0.75
[Iodobenzylguanide-131 therapy as first choice in non-metastasized neuroblastoma]. Ned Tijdschr Geneeskd (1996) 0.75
[Osteomyelitis in newborn infants]. Ned Tijdschr Geneeskd (1989) 0.75
High-quality care for all children with cancer. Ann Oncol (2012) 0.75
Bidirectional differentiation involving a cell with rearrangement of the MLL gene. Leukemia (1998) 0.75
Prophylactic antibiotics for preventing early Gram-positive central venous catheter infections in oncology patients, a Cochrane systematic review. Cancer Treat Rev (2005) 0.75
Primary ovarian insufficiency in children after treatment with 131I-metaiodobenzylguanidine for neuroblastoma: report of the first two cases. J Clin Endocrinol Metab (2013) 0.75
[A boy with acute cerebellar ataxia without opsoclonus caused by neuroblastoma]. Ned Tijdschr Geneeskd (2006) 0.75
Patient reported outcomes in pediatric oncology practice: suggestions for future usage by parents and pediatric oncologists. Pediatr Blood Cancer (2014) 0.75
Stillbirths in relation to the coastline of Cumbria, 1950-89. Paediatr Perinat Epidemiol (1999) 0.75
[Keeping up to date with the relevant literature: 'really simple syndication'-(RSS)-feeds within PubMed]. Ned Tijdschr Geneeskd (2008) 0.75
Meningitis due to a multiply resistant Streptococcus pneumoniae in a child in The Netherlands. Scand J Infect Dis (1992) 0.75